Guggenheim Keeps Universal Health Services at Buy, Cuts Target to $201
Guggenheim maintained its Buy rating on Universal Health Services and lowered its price target to $201 from $209.
Guggenheim maintained its Buy rating on Universal Health Services and lowered its price target to $201 from $209.